{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:04:34Z","timestamp":1784567074603,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","award":["PCF 604934"],"award-info":[{"award-number":["PCF 604934"]}],"id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001353","name":"National Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000125","name":"National Institute for Occupational Safety and Health","doi-asserted-by":"publisher","award":["U01 OH01163"],"award-info":[{"award-number":["U01 OH01163"]}],"id":[{"id":"10.13039\/100000125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jhepr.2023.100696","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T02:26:19Z","timestamp":1675650379000},"page":"100696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Environmental exposures are important risk factors for advanced liver fibrosis in African American adults"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7630-3305","authenticated-orcid":false,"given":"Ning","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6208-2780","authenticated-orcid":false,"given":"Rowena","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amreen","family":"Dinani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-1615","authenticated-orcid":false,"given":"Artit","family":"Jirapatnakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costica","family":"Aloman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena B.","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Dieterich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0184-3803","authenticated-orcid":false,"given":"Brooke","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Yankelevitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Henschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea D.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100696_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100696_bib2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/liv.15295","article-title":"FIB-4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: a Fine\u2013Gray competing risk analysis","volume":"43","author":"Schreiner","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100696_bib3","unstructured":"OHID. Guidance of Liver disease: applying All Our Health. Office for Health\u00a0Improvement and Disparities (OHID) in England. Accessed date: 6\u00a0May 2022. https:\/\/www.gov.uk\/government\/publications\/liver-disease-applying-all-our-health\/liver-disease-applying-all-our-health."},{"key":"10.1016\/j.jhepr.2023.100696_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.29113","article-title":"Liver fibrosis scores predict liver disease mortality in the United States population","volume":"66","author":"Unalp-Arida","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100696_bib5","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100696_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.gastro.2019.09.008","article-title":"Ability\u00a0of\u00a0noninvasive scoring systems to identify individuals in the population at risk for severe liver disease","volume":"158","author":"Hagstr\u00f6m","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100696_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/hep.32545","article-title":"The steatosis-associated fibrosis estimator (SAFE) score: a tool to detect low-risk NAFLD in primary care","volume":"77","author":"Sripongpun","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100696_bib8","article-title":"Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a population-based risk factor assessment using vibration controlled transient elastography (VCTE)","volume":"16","author":"Eskridge W, Vierling JM","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100696_bib9","unstructured":"AASLD. Guidelines and Guidances in Development, Practice Guidelines: Non-Invasive Liver Disease Assessment. Accessed date June 1st, 2022. https:\/\/www.aasld.org\/practice-guidelines."},{"key":"10.1016\/j.jhepr.2023.100696_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100696_bib11","first-page":"1","article-title":"National health and nutrition examination survey: analytic guidelines, 1999\u20132010","volume":"2","author":"Johnson","year":"2013","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jhepr.2023.100696_bib12","series-title":"Public-use linked mortality files","year":"2019"},{"key":"10.1016\/j.jhepr.2023.100696_bib13","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100696_bib14","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2023.100696_bib15","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1001\/jama.2019.19365","article-title":"Prevalence of diabetes by race and ethnicity in the United States, 2011\u20132016","volume":"322","author":"Cheng","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2023.100696_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/HYPERTENSIONAHA.118.11609","article-title":"Prevalence of hypertension and cardiovascular risk according to blood pressure thresholds used for diagnosis","volume":"72","author":"Lamprea-Montealegre","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jhepr.2023.100696_bib17","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/sj.ejcn.1602656","article-title":"Preferred clinical measures of central obesity for predicting mortality","volume":"61","author":"Welborn","year":"2007","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jhepr.2023.100696_bib18","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011\u20132016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jhepr.2023.100696_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008178","article-title":"Electronic cigarette use prevalence, associated factors, and pattern by cigarette smoking status in the United States from NHANES (National Health and Nutrition Examination Survey) 2013\u20132014","volume":"7","author":"Jaber","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhepr.2023.100696_bib20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.amepre.2016.02.033","article-title":"Association of hepatitis C virus with alcohol use among U.S. adults: NHANES 2003\u20132010","volume":"51","author":"Taylor","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jhepr.2023.100696_bib21","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1289\/ehp.1002720","article-title":"Polychlorinated biphenyls, lead, and mercury are associated with liver disease in American adults: NHANES 2003\u20132004","volume":"118","author":"Cave","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jhepr.2023.100696_bib22","first-page":"26","article-title":"Childhood overweight and family income","volume":"9","author":"Freedman","year":"2007","journal-title":"MedGenMed"},{"key":"10.1016\/j.jhepr.2023.100696_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States national health and nutrition examination survey","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100696_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14309\/ajg.0000000000000380","article-title":"Alcoholic liver disease epidemiology in the United States: a retrospective analysis of 3 US databases","volume":"115","author":"Dang","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100696_bib25","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018","author":"Hales","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.jhepr.2023.100696_bib26","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013\u20132016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100696_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.jhepr.2023.100696_bib28","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A\u00a0simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jhepr.2023.100696_bib29","first-page":"12","volume":"49","author":"Yuan","year":"2010"},{"key":"10.1016\/j.jhepr.2023.100696_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.aohep.2020.03.006","article-title":"Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: a nationwide survey (NHANES 2011\u20132016)","volume":"19","author":"Reja","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.jhepr.2023.100696_bib31","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s11605-013-2210-9","article-title":"Cadmium exposure and liver disease among US adults","volume":"17","author":"Hyder","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2023.100696_bib32","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100696_bib33","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2020200107","article-title":"Lung cancer screening in African Americans: the time to act is now","volume":"2","author":"Prosper","year":"2020","journal-title":"Radiol Imaging Cancer"},{"key":"10.1016\/j.jhepr.2023.100696_bib34","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41467-022-28889-2","article-title":"Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control","volume":"13","author":"Montgomery","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2023.100696_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/npjgenmed.2016.18","article-title":"Lead toxicity and genetics in Flint, MI","volume":"1","author":"Taylor","year":"2016","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jhepr.2023.100696_bib36","series-title":"Preventing disease through healthy environments. Exposure to cadmium: a major public health concern","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jhepr.2023.100696_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MEG.0000000000001045","article-title":"Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA","volume":"30","author":"Wijarnpreecha","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100696_bib38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2020.09.017","article-title":"A\u00a0microRNA linking human positive selection and metabolic disorders","volume":"183","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2023.100696_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/hep4.1771","article-title":"Liver cancer has a distinctive profile in Black patients: current screening guidelines may be inadequate","volume":"6","author":"Winters","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2023.100696_bib40","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/cncr.33377","article-title":"Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype","volume":"127","author":"Shaltiel","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jhepr.2023.100696_bib41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/MCG.0000000000000208","article-title":"The epidemiology of cirrhosis in the United States: a population-based study","volume":"49","author":"Scaglione","year":"2015","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100696_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/MEG.0000000000001735","article-title":"African Americans have a distinct clinical and histologic profile with lower prevalence of NASH and advanced fibrosis relative to Caucasians","volume":"33","author":"Satapathy","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100696_bib43","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2217\/fon-2020-1262","article-title":"Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials","volume":"17","author":"Camidge","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.jhepr.2023.100696_bib44","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1037\/hea0000368","article-title":"African American experiences in healthcare: \u201cI always feel like I'm getting skipped over\u201d","volume":"35","author":"Cuevas","year":"2016","journal-title":"Health Psychol"},{"key":"10.1016\/j.jhepr.2023.100696_bib45","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/ijo.2017.309","article-title":"Protective effect of black relative to white race against non-alcoholic fatty liver disease in patients with severe obesity, independent of type 2 diabetes","volume":"42","author":"Browning","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.jhepr.2023.100696_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150978","article-title":"Cirrhosis and advanced fibrosis in Hispanics in Texas: the dominant contribution of central obesity","volume":"11","author":"Jiao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2023.100696_bib47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1196\/annals.1425.032","article-title":"Housing and health: intersection of poverty and environmental exposures","volume":"1136","author":"Rauh","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jhepr.2023.100696_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014746118","article-title":"Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations","volume":"118","author":"Andrasfay","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2023.100696_bib49","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases drom 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100696_bib50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.30161","article-title":"Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555923000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:06:59Z","timestamp":1778904419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555923000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2589555923000277"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100696","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmental exposures are important risk factors for advanced liver fibrosis in African American adults","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100696"}}